• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amylin Pharmaceuticals

Related Topics

  1. King Pharmaceuticals
  2. Endo Pharmaceutical Holdings
  3. Nektar Therapeutics
  4. Fidelity Southern
  5. NPS Pharmaceuticals
  6. Pharmaceutical Product Development

Popular Topics

  1. Germany
  2. France
  3. CDC Corporation A
  4. Singapore
  5. Aberdeen Asia-Pacific Income Fund

Amylin Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Amylin Pharmaceuticals AMLN Q4 2011 Earnings Call Transcript

    Welcome to the Amylin Pharmaceuticals Q4 2011 Earnings Call. At this time, all participants are in a listen-only mode until the question-and-answer session. This conference is being recorded. If you have any objections, please disconnect at this time.

  2. Amylin Pharmaceuticals AMLN Q1 2010 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to the Q1 2010 Amylin Pharmaceuticals Incorporated Earnings Conference Call. At this time, all participants are in listen-only mode. (Operator Instructions).

  3. Amylin Pharmaceuticals AMLN Q4 2010 Earnings Call Transcript

    Welcome to the Amylin Pharmaceuticals Q4 2010 and Year End Earnings Call. At this time, participants are in a listen-only mode until the question-and-answer session. (Operator Instructions). This conference is being recorded. If you have any objections, please disconnect at this time.

  4. Amylin Pharmaceuticals AMLN Q1 2011 Earnings Call Transcript

    Welcome to the Amylin Pharmaceuticals Q1 2011 Earnings Call. At this time, participants are in a listen-only mode until the question-and-answer session. This conference is being recorded. If you have any objections, please disconnect at this time.

  5. Amylin Pharmaceuticals AMLN Q3 2010 Earnings Call Transcript

    Welcome to the Amylin Q3 2010 Earnings Call. At this time participants are in a listen-only mode until the question-and-answer session. This conference is being recorded. If you have any objections, please disconnect at this time.

  6. Former Bristol-Myers Executive Admits to Insider Trading

    Former Bristol-Myers Executive Admits to Insider Trading

  7. Stock Star Rating Performance Update

    As 2005 draws to a close, our performance continues to be solid all around, with some bright spots and a few areas for further improvement. Our contrarian stance on large-cap and energy stocks has weighed on our results recently, but we're still confident that those calls will work out in the end. ...

  8. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

  9. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.